Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

288.22
Delayed Data
As of May 26
 -2.30 / -0.79%
Today’s Change
240.30
Today|||52-Week Range
303.74
+8.61%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Performance

1 month-1.73% 3 years+7.57%
3 months+0.27% 5 years+18.58%
1 year+5.87% Since inception+6.91%
Data through 05/26/2017

Quote Details

Previous close$290.52
Open day’s range288.06 – 291.04
Net asset value (NAV)290.57 (05/25/2017)
Daily volume619,941
Average volume (3 months)1,041,863
Data as of 3:59pm ET, 05/26/2017

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+18.58%+16.30%
Expense Gross exp ratio0.47%1.32%
Risk 5 year sharpe ratio0.891.08
Net assets$8.2B$3.0B
Average market cap$16.2B$28.8B
Average P/E20.823.8
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene7.98%
GILD Gilead Sciences7.73%
BIIB Biogen7.47%
AMGN Amgen7.35%
REGN Regeneron Pharmaceuticals6.49%
VRTX Vertex Pharmaceuticals Inc4.79%
ILMN Illumina Inc4.39%
ALXN Alexion Pharmaceuticals Inc3.87%
INCY Incyte Corp3.71%
MYL Mylan NV3.26%